VEGFA and viral infectious disease: In vivo LSEC are continually exposed to hepatocyte-derived VEGF-A and this growth factor has been proposed to protect the liver against viral infection.5 We therefore measured the effect of VEGF-A on LSEC expression of proviral soluble factors.